These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21793833)

  • 1. Dietary energy balance modulation of epithelial carcinogenesis: a role for IGF-1 receptor signaling and crosstalk.
    Moore T; Checkley LA; DiGiovanni J
    Ann N Y Acad Sci; 2011 Jul; 1229():7-17. PubMed ID: 21793833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues.
    Moore T; Beltran L; Carbajal S; Strom S; Traag J; Hursting SD; DiGiovanni J
    Cancer Prev Res (Phila); 2008 Jun; 1(1):65-76. PubMed ID: 19138937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk.
    Moore T; Beltran L; Carbajal S; Hursting SD; DiGiovanni J
    Cancer Prev Res (Phila); 2012 Oct; 5(10):1236-46. PubMed ID: 22896210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors.
    Dogan S; Johannsen AC; Grande JP; Cleary MP
    Nutr Cancer; 2011; 63(3):389-401. PubMed ID: 21462085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction.
    Kari FW; Dunn SE; French JE; Barrett JC
    J Nutr Health Aging; 1999; 3(2):92-101. PubMed ID: 10885804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
    Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
    Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
    Fang J; Zhou Q; Shi XL; Jiang BH
    Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity.
    Nogueira LM; Dunlap SM; Ford NA; Hursting SD
    Endocr Relat Cancer; 2012 Feb; 19(1):57-68. PubMed ID: 22143497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
    Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H
    Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
    Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growing challenge of obesity and cancer: an inflammatory issue.
    Harvey AE; Lashinger LM; Hursting SD
    Ann N Y Acad Sci; 2011 Jul; 1229():45-52. PubMed ID: 21793838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of angiogenesis and tumor growth by denbinobin is associated with the blocking of insulin-like growth factor-1 receptor signaling.
    Tsai AC; Pan SL; Lai CY; Wang CY; Chen CC; Shen CC; Teng CM
    J Nutr Biochem; 2011 Jul; 22(7):625-33. PubMed ID: 20951021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
    J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GIPC mediates the generation of reactive oxygen species and the regulation of cancer cell proliferation by insulin-like growth factor-1/IGF-1R signaling.
    Choi JS; Paek AR; Kim SY; You HJ
    Cancer Lett; 2010 Aug; 294(2):254-63. PubMed ID: 20206441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.